1. Home
  2. ACR vs NYXH Comparison

ACR vs NYXH Comparison

Compare ACR & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$18.59

Market Cap

146.1M

Sector

Real Estate

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$1.45

Market Cap

126.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
NYXH
Founded
2005
2009
Country
United States
Belgium
Employees
4
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.1M
126.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ACR
NYXH
Price
$18.59
$1.45
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$24.50
$9.33
AVG Volume (30 Days)
16.2K
35.7K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$213.98
Revenue Next Year
N/A
$126.25
P/E Ratio
$19.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.06
$2.68
52 Week High
$24.61
$8.59

Technical Indicators

Market Signals
Indicator
ACR
NYXH
Relative Strength Index (RSI) 33.26 19.11
Support Level $17.56 N/A
Resistance Level $19.64 $5.02
Average True Range (ATR) 0.58 0.16
MACD -0.20 -0.09
Stochastic Oscillator 4.58 4.35

Price Performance

Historical Comparison
ACR
NYXH

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: